CA2513769A1 - Method for evaluating the efficacy of certain cancer treatments - Google Patents

Method for evaluating the efficacy of certain cancer treatments Download PDF

Info

Publication number
CA2513769A1
CA2513769A1 CA002513769A CA2513769A CA2513769A1 CA 2513769 A1 CA2513769 A1 CA 2513769A1 CA 002513769 A CA002513769 A CA 002513769A CA 2513769 A CA2513769 A CA 2513769A CA 2513769 A1 CA2513769 A1 CA 2513769A1
Authority
CA
Canada
Prior art keywords
sample
fragment
therapeutic agent
caspase
kda
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002513769A
Other languages
English (en)
French (fr)
Inventor
Esther H. Chang
Kathleen F. Pirollo
Antonina Rait
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Georgetown University
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2513769A1 publication Critical patent/CA2513769A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
CA002513769A 2003-01-28 2004-01-28 Method for evaluating the efficacy of certain cancer treatments Abandoned CA2513769A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US44290203P 2003-01-28 2003-01-28
US60/442,902 2003-01-28
PCT/US2004/002261 WO2004066946A2 (en) 2003-01-28 2004-01-28 Method for evaluating the efficacy of certain cancer treatments

Publications (1)

Publication Number Publication Date
CA2513769A1 true CA2513769A1 (en) 2004-08-12

Family

ID=32825276

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002513769A Abandoned CA2513769A1 (en) 2003-01-28 2004-01-28 Method for evaluating the efficacy of certain cancer treatments

Country Status (5)

Country Link
US (1) US20040241088A1 (https=)
EP (1) EP1595142A4 (https=)
JP (1) JP2006517032A (https=)
CA (1) CA2513769A1 (https=)
WO (1) WO2004066946A2 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8617514B2 (en) 1999-02-22 2013-12-31 Georgetown University Tumor-targeted nanodelivery systems to improve early MRI detection of cancer
AU2006304790B2 (en) * 2005-10-20 2013-06-27 Georgetown University Tumor-targeted nanodelivery systems to improve early MRI detection of cancer
CN102325719A (zh) 2008-12-30 2012-01-18 3M创新有限公司 纳米结构化制品和制备纳米结构化制品的方法
US20140120157A1 (en) 2012-09-19 2014-05-01 Georgetown University Targeted liposomes
WO2020117715A1 (en) 2018-12-03 2020-06-11 Board Of Regents, The University Of Texas System Oligo-benzamide analogs and their use in cancer treatment
JPWO2022075439A1 (https=) * 2020-10-08 2022-04-14

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6462175B1 (en) * 1995-11-13 2002-10-08 Thomas Jefferson University Mch3, a novel apoptotic protease, nucleic acids encoding and methods of use
AU759164C (en) * 1997-11-19 2007-03-29 Georgetown University Targeted liposome gene delivery
ATE511543T1 (de) * 1999-02-22 2011-06-15 Univ Georgetown Immunoliposome mit einem targeting- antikörperfragment zur systemischen genverabreichung
US6391575B1 (en) * 1999-03-05 2002-05-21 Idun Pharmaceuticals, Inc. Methods for detecting membrane derived caspase activity and modulators thereof
US6887851B2 (en) * 2001-09-18 2005-05-03 Bioexpertise, Llc IGF-binding protein-derived peptide

Also Published As

Publication number Publication date
JP2006517032A (ja) 2006-07-13
WO2004066946A3 (en) 2005-08-18
US20040241088A1 (en) 2004-12-02
WO2004066946A2 (en) 2004-08-12
EP1595142A4 (en) 2006-08-23
EP1595142A2 (en) 2005-11-16

Similar Documents

Publication Publication Date Title
Sugawara et al. Lung resistance protein (LRP) expression in human normal tissues in comparison with that of MDR1 and MRP
Pakunlu et al. Enhancement of the efficacy of chemotherapy for lung cancer by simultaneous suppression of multidrug resistance and antiapoptotic cellular defense: novel multicomponent delivery system
EP1429797B1 (en) Diagnosis and treatment of malignant neoplasms
Jung et al. A peptide probe enables photoacoustic-guided imaging and drug delivery to lung tumors in K-rasLA2 mutant mice
Rodriguez et al. Expression of P-glycoprotein and anionic glutathione S-transferase genes in non-Hodgkin's lymphoma
US20070122414A1 (en) Surface marker-directed cancer therapeutics
US8048415B2 (en) Compositions and methods for promoting or inhibiting angiogenesis
US20070077583A1 (en) Alpha enolase-directed diagnostics and therapeutics for cancer and chemotherapeutic drug resistance
US20040241088A1 (en) Method for evaluating the efficacy of certain cancer treatments
JP2008163029A (ja) ＰＡＰ２ａに対する抗体ならびにその診断的および治療的使用
ES2371479T3 (es) Uso de aimp2dx2 para el diagnóstico y tratamiento del cáncer.
ES2302692T3 (es) Coligina/hsp47 localizada en la superficie en celulas de carcinoma.
US6953658B2 (en) Method of diagnosing, monitoring, staging, imaging and treating gastrointestinal cancer
CA3235029A1 (en) Method of cancer treatment
JP2002095476A (ja) トランスフェリン受容体を介した遺伝子導入法
US7419792B2 (en) Laminin Receptor 1 Precursor Protein (37LRP) epitope delineated by an Hepatocellular carcinoma specific antibody
JP2006517032A5 (https=)
WO2003099199A2 (en) Compositions and methods for promoting or inhibiting angiogenesis
TWI335327B (en) Pharmaceutical composition for huntington's disease treatment
Bader Targeting Cell Surface GRP78 for Specific Nanoparticle Mediated Drug Delivery to Breast Cancer
US20050043262A1 (en) Novel specific inhibitor of the cyclin kinase inhibitor p21Waf1/Cip1 and methods of using the inhibitor
WO2012133994A1 (ko) Pauf 및 그의 결합 파트너를 상호작용을 이용한 암 치료제의 스크리닝 방법
Broer et al. Preclinical T cell imaging with positron emission tomography using CD4 and CD8 targeting 89Zr-F (ab’) 2 fragments
Narayan et al. Focal Therapy for Prostate Cancer: A Molecular Biology Approach with TRAIL
Ginsberg et al. Franco DeMonte, Chrisstopher G. Kalhorn (Houston, TX)

Legal Events

Date Code Title Description
FZDE Discontinued
FZDE Discontinued

Effective date: 20100128